Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D3 receptor | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | plexin a4 | 0.0285 | 0.6246 | 1 |
Loa Loa (eye worm) | plexin A | 0.0285 | 0.6246 | 0.6246 |
Loa Loa (eye worm) | hypothetical protein | 0.0327 | 0.8071 | 0.8071 |
Loa Loa (eye worm) | hypothetical protein | 0.0371 | 1 | 1 |
Schistosoma mansoni | plexin | 0.0241 | 0.4343 | 0.4343 |
Loa Loa (eye worm) | TK/ALK protein kinase | 0.0292 | 0.6559 | 0.6559 |
Brugia malayi | plexin A | 0.0285 | 0.6246 | 0.3364 |
Onchocerca volvulus | 0.0241 | 0.4343 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.0923 | 0.0923 |
Brugia malayi | Protein kinase domain containing protein | 0.0292 | 0.6563 | 0.3924 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0161 | 0.0923 | 0.0923 |
Echinococcus multilocularis | plexin a4 | 0.0285 | 0.6246 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.0923 | 0.0923 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.0371 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0371 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.4343 | 0.4343 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 0.4553 | 0.4553 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | 0 uM kg-1 | The compound was tested in vivo for DOPA accumulation in limbic system against reserpine-pretreated rats; I=inactive at the highest dose tested | ChEMBL. | 7783152 |
ED50 (functional) | 0 uM kg-1 | compound was tested in vivo for DOPA accumulation in corpus striatum against reserpine-pretreated rats; I=inactive at the highest dose tested | ChEMBL. | 7783152 |
ED50 (functional) | 0 uM kg-1 | The compound was tested in vivo for DOPA accumulation in hemispheres(cortex) against reserpine-pretreated rats;I= inactive at the highest dose tested | ChEMBL. | 7783152 |
ED50 (functional) | 0 uM kg-1 | compound was tested in vivo for 5-HTP accumulation in limbic system against reserpine-pretreated rats;I= inactive at the highest dose tested | ChEMBL. | 7783152 |
ED50 (functional) | 0 uM kg-1 | compound was tested in vivo for 5-HTP accumulation in corpus striatum against reserpine-pretreated rats, activity expressed as ED50;I= inactive at the highest dose tested | ChEMBL. | 7783152 |
ED50 (functional) | 0 uM kg-1 | compound was tested in vivo for 5-HTP accumulation in hemispheres(cortex) against reserpine-pretreated rats;I= inactive at the highest dose tested | ChEMBL. | 7783152 |
Ki (binding) | = 40 nM | Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]-8-OH-DPAT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 40 nM | Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]-8-OH-DPAT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 334 nM | Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 334 nM | Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 439 nM | Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 439 nM | Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 510 nM | Binding affinity against Dopamine receptor D2 from CHO-K1 cells, using [3H]-U-86,170 as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 510 nM | Binding affinity against Dopamine receptor D2 from CHO-K1 cells, using [3H]-U-86,170 as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 1012 nM | Binding affinity against Dopamine receptor D3 from CHO-K1 cells, using [3H]-spiperone as the radioligand. | ChEMBL. | 7783152 |
Ki (binding) | = 1012 nM | Binding affinity against Dopamine receptor D3 from CHO-K1 cells, using [3H]-spiperone as the radioligand. | ChEMBL. | 7783152 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.